Introduction
Angiopoietins and their specific receptor tyrosine kinase, Tie 2, are implicated in the regulation of vascular and lymphatic vessel development and pathophysiological angiogenesis.
Angiopoietin 1 (Ang1) positively stimulates angiogenesis in certain tumors [1] [2] [3] [4] , inducing proliferation, migration and survival of endothelial cells [5] [6] [7] . Thus, Tie 2 signaling represents a potential target for the treatment of advanced cancers in human. Cellular responses in Ang1-treated endothelial cells are largely regulated through the Ras/mitogen-activated protein kinase and phosphoinositide 3-kinase/Akt pathways [5, 6] . However, the role of Src family kinases in Ang1-induced cellular responses of endothelial cells has not yet been determined.
The Src family of protein tyrosine kinases plays a role in tumor progression and angiogenesis [8, 9] . Src family kinases have been linked to angiogenic cellular responses of endothelial cells as well as in vivo angiogenesis promoted by fibroblast growth factor-2 (FGF-2), Ang2, vascular endothelial growth factor-A (VEGF-A), and hepatocyte growth factor [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] . Recently, anti-VEGF receptor-2 (VEGFR-2) blocking antibody inhibited angiogenesis and initial tumor growth in a mouse pancreatic islet tumor model. However, VEGFR-2 blockade alone failed to inhibit late-stage tumor growth, which was driven by FGF-2-induced angiogenesis [22] . This result suggested that blocking VEGF alone may induce VEGF-resistant angiogenesis and that the simultaneous inhibition of signal transduction pathways driven through multiple proangiogenic factor receptors may be required for complete inhibition of angiogenesis. Synthetic small-molecule protein kinase inhibitors, such as Src inhibitor PP2, may thus have the potential to block angiogenesis in advanced human cancers. oxygen in air), the oxygen tension of the culture medium is approximately 160 mmHg [23] .
Oxygen tension in normal human end-capillary blood is 45-50 mmHg, whereas that in hypoxic tumor tissue is 8-10 mmHg [24] . Thus, it is possible that the sensitivity of endothelial cells to synthetic small-molecule protein kinase inhibitors may differ under normoxic and hypoxic (1.5-2.0% O 2 ) conditions. The present study was designed to determine the role of Src in the signal transduction pathways leading to Ang1-induced capillary morphogenesis in both normoxia and hypoxia.
The results showed that the sensitivity of Ang1-induced capillary morphogenesis to a Src family kinase inhibitor, PP2, was attenuated in endothelial cells cultured under chronic hypoxic conditions, possibly via upregulation of multidrug resistance-associated protein 1 (MRP 1). The final concentration of DMSO in the culture medium was always 0.1% (V/V). Verapamil was obtained from Wako Pure Chemicals (Osaka, Japan), and was dissolved in water immediately before use. 
Materials and methods

Materials
Anti
Cell culture
Transfection of siRNA
HUVECs were transfected with the indicated siRNA using HiPerFect  reagent.
After 2 days, cells were detached from the wells and submitted to a capillary morphogenesis assay. Four thousand cells from each treatment were lysed and expression of Src and MRP 1 was examined by immunoblotting.
Capillary morphogenesis assay
The capillary morphogenesis assay was carried out as described previously [25] .
In brief, HUVECs suspended in culture medium containing 0.5% FBS were inoculated onto growth factor-reduced Matrigel  , with or without treatment, and cultured for 24 h. To quantify Kanda S et al, Page 8 the length of capillaries, three different phase-contrast photomicrographic images (x 4 objective) per well were taken, and the length of each capillary was measured using NIH image analysis software (version 1.64). Capillary length for cells without any treatment was set to 1.0.
Values are expressed as means ± SD of three images. To examine the kinetics of capillary morphogenesis, cells seeded onto Matrigel were serially photographed at indicated periods.
Immunoblot analyses
Two sets of cultures in 24-well plates were prepared; one set was used for min. Cells were washed with Tris-buffered saline, lysed in lysis buffer [7] , and tyrosine phosphorylation of Src or Tie 2 was examined by immunoprecipitation followed by immunoblotting. Band intensities were quantified from scanned images of the blots using NIH Image (version 1.64). The relative ratio of the expressed amount of Src or MRP 1 was calculated as the ratio of Src or MRP 1 signal divided by the corresponding vinculin signal;
each value was then normalized to the ratio obtained from control siRNA-transfected cells.
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Measurement of secreted VEGF-A by HUVECs
Two days after transfecion with either control or Src siRNA, HUVECs were suspended in medium containing 0.5% FBS, with or without 200 ng/ml Ang1, and seeded into 12-well plates. Twenty-four hours later, culture medium was collected and the concentration of VEGF-A was quantified using the Quantikine ® human VEGF-A ELISA kit according to the protocol provided by the manufacturer, to a sensitivity of 15 pg/ml VEGF. Culture medium not incubated with HUVECs was used as a background value. The values are expressed as mean concentration ± SD for triplicate wells.
In vitro kinase assay
In vitro kinase assay for Src was described previously [21] . In brief, cells were serum-starved for 2 h and were treated with either PP2 or 0.1% DMSO. One hour later, cells were either stimulated or left unstimulated with Ang1 for 10 min. Src was immunoprecipitated and kinase assay was performed by the use of acid-denatured enolase as a substrate.
Incorporation of [-32 P] ATP into enolase was examined by SDS-PAGE, followed by autoradiography.
Statistical analysis
Values are presented as mean length ± SD. Differences between two groups were analyzed using the Mann-Whitney's U test. Differences were considered significant when the P value was less than 0.05.
Results
Ang1 induces capillary morphogenesis by HUVECs cultured under both normoxic and hypoxic conditions
First, we showed that Ang1 was able to induce capillary morphogenesis of HUVECs cultured under normoxic or hypoxic conditions, in a dose-dependent manner (Fig. 1 ).
The morphological changes were similar under both conditions of oxygen tension; cells became elongated and fused in the presence of Ang1.
Src is involved in Ang1-induced capillary morphogenesis by HUVECs
In light of the reported role of Src family kinases in tube formation or capillary morphogenesis of endothelial cells [11, 12, 14, 20, 21] , we next examined the effect of expression of Src on Ang1-induced capillary morphogenesis by using siRNA technique. The Src siRNA at 10 nM downregulated endogenous Src expression in HUVECs by ~75% compared to control siRNA-treated cells under both normoxic and hypoxic conditions, as assessed by densitometry ( Fig. 2A ). Fyn and Yes were not affected in the same experiments (data not shown). Downregulation of Src also potently inhibited Ang1-induced capillary morphogenesis by HUVECs cultured under both normoxic and hypoxic conditions (Fig. 2B ),
implicating Src in this process regardless of the ambient oxygen concentration. As shown in 
Src-dependent upregulation of VEGF-A is involved in Ang1-induced capillary morphogenesis
We have previously shown that FGF-2-induced capillary morphogenesis by HUVECs requires endogenous VEGF-A-mediated signaling through VEGFR-1 [26] . In this report, the FGF-2-induced protrusion and extension of endothelial cells was inhibited in the presence of blocked VEGF-A signaling. In the fibroblast/endothelial cell co-culture model, VEGFR-2-mediated signaling via endogenous VEGF-A was required for Ang1-induced tube formation [27] , and expression of VEGF-A was regulated through Src under normoxic and hypoxic conditions [28, 29] . These results suggest that endogenous VEGF-A may participate in Ang1-induced capillary morphogenesis. We therefore measured the secretion of VEGF-A by HUVECs cultured under both normoxic and hypoxic conditions. Cells transfected with either control or Src siRNA were cultured and culture medium was collected in the presence or absence of Ang1. Control siRNA-transfected cells showed significantly upregulated VEGF-A secretion following Ang1 treatment under both normoxic and hypoxic conditions, whereas Src siRNA transfection markedly downregulated the VEGF-A secretion by HUVECs (Fig. 3 ). This result indicated that Ang1 may stimulate the secretion of VEGF-A via Src family kinases. We next examined the effect of a blocking antibody against human VEGF-A, which inhibits the activity of human VEGF-A, but not of mouse VEGF-A [26] , on Ang1-induced capillary morphogenesis. As shown in Fig. 4A , the VEGF-A blocking antibody significantly inhibited Ang1-induced capillary morphogenesis by HUVECs cultured under both normoxic and hypoxic conditions. Mouse VEGF-A (a ligand for both VEGFR-1 and -2), but not human PlGF-1 (a ligand only for VEGFR-1), restored this inhibition, suggesting that endogenous VEGF-mediated signaling through both VEGF-1 and VEGFR-2 was required for Ang1-induced capillary morphogenesis. We further examined the effect of exogenous Kanda S et al, Page 12 VEGF-A on Ang1-induced capillary morphogenesis by Src-depleted HUVECs. As shown in Fig. 4B , exogenous VEGF-A restored Ang1-induced capillary morphogenesis in the Src-depleted HUVECs, but had no effect on the Ang1-induced capillary morphogenesis by
HUVECs transfected with control siRNA. Exogenous VEGF-A also induced cell spreading on Matrigel and protrusion followed by network formation (Fig. 4C) . These results suggest that Ang1-induced capillary morphogenesis requires Src-dependent secretion of endogenous VEGF-A.
Inhibition of Ang1-induced capillary morphogenesis in HUVECs by Src inhibitor PP2 is impaired under hypoxic culture conditions.
We next examined the effect of Src family kinase inhibitor PP2 on Ang1-induced capillary morphogenesis by HUVECs, and showed a significant inhibition under normoxic conditions (Fig. 5A ). However, under hypoxic conditions, the sensitivity of Ang1-induced capillary morphogenesis to PP2 treatment was decreased. The effect of PP2 on Src activity in HUVECs was then examined. As shown in Figure 5B , Ang1 activated Src in HUVECs cultured under both normoxic and hypoxic conditions. However, PP2 did not efficiently decrease the Src activity in HUVECs cultured under hypoxic conditions, suggesting that the effect of PP2 is impaired in hypoxic cells. Immunoblot analysis by using phospho-specific antibodies against Src showed that PP2 decreased the pY418 of Src in HUVECs cultured under normoxic conditions, but not in HUVECs cultured under hypoxic conditions (Fig. 5C ). We also showed that an upstream regulator of Src, Tie 2 receptor tyrosine kinase was efficiently autophosphorylated in HUVECs cultured under both normoxic and hypoxic conditions in the presence of Ang1 (Fig. 5D) , suggesting that the activation of Tie 2 was not affected by chronic hypoxia.
Impaired action of PP2 may be due to the upregulation of MRP 1
Under hypoxic conditions, the multidrug resistance (MDR 1) gene is upregulated through HIF-1 [30] . The impaired effect of PP2 under these conditions in HUVECs may therefore be due to an elevated expression of MDR 1 protein.
To address this, we treated
HUVECs with a broad MDR inhibitor, verapamil, and then examined the effect of PP2.
Verapamil at 0.2 M significantly restored the inhibitory action of PP2 on Ang1-induced capillary morphogenesis and Src activation (data not shown). Since expression of MDR 1 protein was not altered by chronic hypoxia in HUVECs, we examined the expression of another transporter protein, MRP 1, the action of which is also inhibited by verapamil [31] . To compare the effect of acute and chronic hypoxia, some of the HUVECs cultured under normoxic conditions were transferred to hypoxic culture conditions for 8 h only. As shown in (Fig. 6B) , and in these cells, Ang1-induced Src activation was inhibited by PP2 (Fig. 6C) . Furthermore, the sensitivity of capillary morphogenesis by HUVECs to PP2 was restored by the MRP 1 depletion (Figure 6D ), suggesting that MRP 1 is important for the sensitivity of HUVECs to PP2 under hypoxic conditions.
Discussion
Endogenous VEGF-A contributes to Ang1-induced capillary morphogenesis by HUVECs
The signal transduction pathways that result in tube formation or capillary morphogenesis by Ang1-treated endothelial cells are poorly understood. The present study 
The effect of PP2 was impaired in HUVECs chronically exposed to hypoxia.
Molecular targeting therapies in the future are expected to control advanced cancers in human. In particular, small-molecule protein kinase inhibitors have been tested widely clinical trials due to their easy accessibility (most are administered orally) and broad spectrum to a panel of protein kinases (targeting different kinds of kinases simultaneously).
These reagents also inhibit both tumor progression and angiogenesis. In the present study, [33] . Interestingly, the action of a protein tyrosine kinase inhibitor of the 2-phenylaminopyrimidine series, imatinib, is impaired in imatinib-resistant leukemia cells [34] and is exported via MDR [35] . In addition, low expression of MRP 1 was a significant predictive factor of imatinib sensitivity in chronic myeloid leukemia [36] . Based on these findings and the results of this study, testing of small molecule protein kinase inhibitors in patients with advanced cancers should consider the activity of ABC membrane transporters. HUVECs grown in 10-cm dishes were serum-starved for 2 h and were either stimulated or left unstimulated with 200 ng/ml of Ang1 for 10 min. Tie 2 was immunoprecipitated and autophosphorylation was examined by immunoblotting. 
